Latest Stock Buy or Sell? Make More Informed Decisions!

Canadian personal and commercial businesses are excellent and dominant. US business is a fixer-upper, and they will. Wholesale business is subject to the vagaries of the capital markets. Wealth management is quite good. Watch DIY investing, as it seems to be doubling down on growth aspirations. Liked the Schwab sale; using proceeds to buy back shares. Dark clouds are finally parting.

The best Canadian bank.

He can't explain the big drop today, but a 6% drop in this name is unusual. Chart shows what a good company it is. Operates in Canada, US, Europe, and India. Should be advantaged by near-shoring. Lots of US government customers, and that should play well with Trump 2.0.

Stable grower, well managed. Drawdown is probably a buyable opportunity.

Applauds decision to reverse course on moving to US. Pretty weak Q4, drawdown of 40%. Since 2000, stock's generated total return of 16,000%, so pullbacks are buyable. Management capable of addressing and resolving problems. Good consolidator of fragmented industry. Now trading at 14x PE, discount to its 5-year average of 16x. Incredible entry point. Yield is 2%.

Now a $14B market cap, an emerging large-cap company. Likes last year's acquisition of Argonaut. Great organic growth profile of 12% annual compound growth rate in production -- no mid- or large-cap can match that. Negligible geopolitical risk of Canada and Mexico. Yield is 0.4%.

World's largest ag-crop nutrient business. Vertically integrated. Believes prices for its input commodities have bottomed, supported by high and rising cash-crop prices. Farmers have to replace nutrients in soil, which was delayed while prices were so high. Trades at book value. Bounced off lows, but still sees upside. In his dividend growers mandate. Yield is 4%.

Selling partially as a source of cash and to rotate shares. Nothing wrong with the company. IS up 14% in February.

Has less exposure to tariffs. Earnings 3 weeks ago where they maintained forecast: over 20% earnings growth in the next 2-3 years, trading at 18x 2025 and 16.5x 2026, and pays nearly 4% dividend, which keeps raising.

He bought more today on the dip. Trades at 24x earnings, expecting that to grow 50% this year. The growth rate will one day drop off, but now now. It boasted a triple beat and remains the leader of semis.

His best performer so far this year, up 12%. Well-managed. They replaced Humira with hit drugs and added key companies; pays a 3.2% dividend. 

She's up 160%, so she trimmed it. It's fairly rich. Are better opportunities in data centres like Eaton. Would buy back GEV at better levels.

She trimmed GE Vernoa to buy more Eaton and Quanta Services, and both just reported blow-out quarters. Quanta: EBITDA +40%, backlog +14%. Eaton: data centres +45%, pipeline +65%, and backlog 3x more than normal. Good valuations.

She trimmed GE Vernoa to buy more Eaton and Quanta Services, and both just reported blow-out quarters. Quanta: EBITDA +40%, backlog +14%. Eaton: data centres +45%, pipeline +65%, and backlog 3x more than normal. Good valuations.

Fine growth and amazing turnaround story.

Has a great platform strategy and products; growing cash flow to $4.5 billion by year's end. Will rebound as they execute.